Dr. Deepa Rangachari
Overview
Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as an Experienced provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.
Her clinical research consists of co-authoring 86 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pancreatic Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
330 Brookline Avenue, Shapiro 9, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Dana-Farber Brigham Cancer Center In Clinical Affiliation With South Shore Health
Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. He joined the staff of DFCI and Brigham and Women's Hospital in 2007, where he is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, and mechanisms by which lifestyle factors interact with malignant risk and progression. Dr. Wolpin is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy.
The General Hospital Corporation
Colin Weekes is an Oncologist in Waltham, Massachusetts. Dr. Weekes is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Tissue Biopsy, and Pancreatectomy.
The General Hospital Corporation
Jeffrey Clark is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Clark is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Clark is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung CancerDr. Rangachari isElite. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Rangachari isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Rangachari isElite. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Rangachari isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Large-Cell Lung CarcinomaDr. Rangachari isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Rangachari isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Rangachari isDistinguished. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Rangachari isDistinguished. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Rangachari isDistinguished. Learn about Primitive Neuroectodermal Tumor (PNET).
- Advanced
- Breast CancerDr. Rangachari isAdvanced. Learn about Breast Cancer.
- MesenchymomaDr. Rangachari isAdvanced. Learn about Mesenchymoma.
- Metastatic Brain TumorDr. Rangachari isAdvanced. Learn about Metastatic Brain Tumor.
- Thymic Epithelial TumorDr. Rangachari isAdvanced. Learn about Thymic Epithelial Tumor.
- Undifferentiated Pleomorphic SarcomaDr. Rangachari isAdvanced. Learn about Undifferentiated Pleomorphic Sarcoma.
- Experienced
- Anal CancerDr. Rangachari isExperienced. Learn about Anal Cancer.
- Familial Pancreatic CancerDr. Rangachari isExperienced. Learn about Familial Pancreatic Cancer.
- Inflammatory Breast CancerDr. Rangachari isExperienced. Learn about Inflammatory Breast Cancer.
- Liver CancerDr. Rangachari isExperienced. Learn about Liver Cancer.
- Lung NodulesDr. Rangachari isExperienced. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaDr. Rangachari isExperienced. Learn about Lymphofollicular Hyperplasia.